SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy

NCT07687160 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Spironolactone (drug)
DRUG: Candesartan 8mg
DRUG: Hydrochlorothiazide (HCTZ) 25 milligrams.
DRUG: Amlodipine (5mg)

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]